Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 2
2006 5
2007 3
2008 3
2009 4
2010 3
2013 3
2014 6
2015 6
2017 1
2018 6
2019 3
2020 2
2021 5
2022 5
2023 3
2024 1
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia.
Brown JR, Seymour JF, Jurczak W, Aw A, Wach M, Illes A, Tedeschi A, Owen C, Skarbnik A, Lysak D, Eom KS, Šimkovič M, Pavlovsky MA, Kater AP, Eichhorst B, Miller K, Munugalavadla V, Yu T, de Borja M, Ghia P; AMPLIFY investigators; AMPLIFY Investigators. Brown JR, et al. N Engl J Med. 2025 Feb 20;392(8):748-762. doi: 10.1056/NEJMoa2409804. Epub 2025 Feb 5. N Engl J Med. 2025. PMID: 39976417 Clinical Trial.
Glofitamab in relapsed/refractory diffuse large B-cell lymphoma: Real-world data.
Birtas Atesoglu E, Gulbas Z, Uzay A, Ozcan M, Ozkalemkas F, Dal MS, Kalyon H, Akay OM, Deveci B, Bekoz H, Sevindik OG, Toptas T, Yilmaz F, Koyun D, Alkis N, Alacacioglu I, Sonmez M, Yavasoglu I, Tombak A, Mehtap O, Kurnaz F, Yuce OK, Karakus V, Turgut M, Kurekci DD, Ayer M, Keklik M, Buyuktas D, Ozbalak M, Ferhanoglu B. Birtas Atesoglu E, et al. Among authors: alacacioglu i. Hematol Oncol. 2023 Oct;41(4):663-673. doi: 10.1002/hon.3174. Epub 2023 May 22. Hematol Oncol. 2023. PMID: 37211991
Bortezomib-induced skin lesion.
Ozcan MA, Alacacioglu I, Piskin O, Lebe B, Turgut N, Ceneli S, Demirkan F, Ozsan GH, Undar B. Ozcan MA, et al. Among authors: alacacioglu i. Acta Haematol. 2006;116(3):226-7. doi: 10.1159/000094689. Acta Haematol. 2006. PMID: 17016047 No abstract available.
Early Access Program Results From Turkey and a Literature Review on Daratumumab Monotherapy Among Heavily Pretreated Patients With Relapsed/Refractory Myeloma.
Beksac M, Aydin Y, Goker H, Turgut M, Besisik SK, Cagirgan S, Tuglular T, Vural F, Yagci M, Alacacioglu I, Aytan P, Goksoy HS, Gulbas Z, Gunes AK, Gurkan E, Hacioglu SK, Karti SS, Kaynar L, Ozdogu H, Paydas S, Solmaz S, Sonmez M, Tekgunduz E, Yildirim R, Ilhan O. Beksac M, et al. Among authors: alacacioglu i. Clin Lymphoma Myeloma Leuk. 2020 Aug;20(8):e474-e484. doi: 10.1016/j.clml.2020.02.017. Epub 2020 Mar 7. Clin Lymphoma Myeloma Leuk. 2020. PMID: 32482539 Free article. Review.
Rare Clinical Sign of Hodgkin's Lymphoma: Ocular Involvement.
Ayhan Z, Yıldırım Karabağ R, Alacacıoğlu İ, Kaynak S, Koçak N. Ayhan Z, et al. Among authors: alacacioglu i. Turk J Ophthalmol. 2017 Apr;47(2):110-112. doi: 10.4274/tjo.92609. Epub 2017 Apr 1. Turk J Ophthalmol. 2017. PMID: 28405486 Free PMC article.
Does imatinib mesylate therapy cause growth hormone deficiency?
Kebapcilar L, Bilgir O, Alacacioglu I, Payzin B, Bilgir F, Oner P, Sari I, Calan M, Binicier O. Kebapcilar L, et al. Among authors: alacacioglu i. Med Princ Pract. 2009;18(5):360-3. doi: 10.1159/000226288. Epub 2009 Jul 31. Med Princ Pract. 2009. PMID: 19648757 Free article.
Images in Hematology.
Özcan MA, Pişkin Ö, Alacacıoğlu İ, Savran Y, Özsan HG. Özcan MA, et al. Among authors: alacacioglu i. Turk J Haematol. 2004 Mar 5;21(1):49. Turk J Haematol. 2004. PMID: 27263648 No abstract available.
59 results